Death in the emergency department: An unrecognized awake malignant hyperthermia-like reaction in a six-year-old

Anesthesia and Analgesia

Volumn 116, Issue 2, 2013, Pages 420-423

  Lavezzi, Wendy A ^a   Capacchione, John F ^b   Muldoon, Sheila M ^b   Sambuughin, Nyamkhishig ^b   Bina, Saiid ^b   Steele, Deanna ^c   Brandom, Barbara W ^d,e  

^a Office of the District 5 Medical Examiner   (United States)

^b Uniformed Services University of the Health Sciences   (United States)

^c Center for Medical Genetics   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e North American Malignant Hyperthermia Registry (NAMHR)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ATROPINE; BICARBONATE; CEFTRIAXONE; CREATINE KINASE; CREATINE KINASE MB; DIAZEPAM; ETOMIDATE; LORAZEPAM; PARACETAMOL; PROPOFOL; RYANODINE RECEPTOR 1; SUXAMETHONIUM; CENTRAL MUSCLE RELAXANT; HYPNOTIC SEDATIVE AGENT; NEUROMUSCULAR DEPOLARIZING AGENT; RYANODINE RECEPTOR;

ARTERIAL GAS; ARTICLE; AWAKE MALIGNANT HYPERTHERMIA; CASE REPORT; CENTRAL CORE DISEASE; CHILD; CHILD DEATH; CREATINE KINASE BLOOD LEVEL; DEHYDRATION; EMERGENCY WARD; ENDOTRACHEAL TUBE; FEVER; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HEART ARREST; HISTOLOGY; HUMAN; LEUKOCYTE COUNT; LORDOSIS; MALE; MALIGNANT HYPERTHERMIA; MUSCLE CONTRACTURE; MUSCLE RIGIDITY; POTASSIUM BLOOD LEVEL; PRESCHOOL CHILD; PRIORITY JOURNAL; RECTUM TEMPERATURE; RESUSCITATION; SWEATING; SYMPTOM; TACHYCARDIA; TONIC CLONIC SEIZURE; TRISMUS; UREA NITROGEN BLOOD LEVEL; ADULT RESPIRATORY DISTRESS SYNDROME; CHEMICALLY INDUCED DISORDER; CHEMISTRY; EMERGENCY HEALTH SERVICE; ENDOTRACHEAL INTUBATION; FATALITY; GENETICS; LIVER; PATHOLOGY; PATHOPHYSIOLOGY;

CHILD; DIAZEPAM; EMERGENCY MEDICAL SERVICES; EMERGENCY SERVICE, HOSPITAL; FATAL OUTCOME; HUMANS; HYPNOTICS AND SEDATIVES; INTUBATION, INTRATRACHEAL; LIVER; LORAZEPAM; MALE; MALIGNANT HYPERTHERMIA; MUSCLE RELAXANTS, CENTRAL; MUSCLE RIGIDITY; MYOPATHY, CENTRAL CORE; NEUROMUSCULAR DEPOLARIZING AGENTS; RESPIRATORY DISTRESS SYNDROME, ADULT; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SUCCINYLCHOLINE;

MLCS; MLOWN;

EID: 84872862436     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3182768f99     Document Type: Article

References (16)

1. Nelson TE. Malignant hyperthermia: a pharmacogenetic disease of Ca++ regulating proteins. Curr Mol Med 2002;2:347-69
2. Gronert GA, Thompson RL, Onofrio BM. Human malignant hyperthermia: awake episodes and correction by dantrolene. Anesth Analg 1980;59:377-8
3. Tobin JR, Jason DR, Challa VR, Nelson TE, Sambuughin N. Malignant hyperthermia and apparent heat stroke. JAMA 2001;286:168-9
4. Groom L, Muldoon SM, Tang ZZ, Brandom BW, Bayarsaikhan M, Bina S, Lee HS, Qiu X, Sambuughin N, Dirksen RT. Identical de novo mutation in the type 1 ryanodine receptor gene associated with fatal, stress-induced malignant hyperthermia in two unrelated families. Anesthesiology 2011;115:938-45
5. MacLennan DH, Duff C, Zorzato F, Fujii J, Phillips M, Korneluk RG, Frodis W, Britt BA, Worton RG. Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature 1990;343:559-61
6. Larach MG, Rosenberg H, Gronert GA, Allen GC. Hyperkalemic cardiac arrest during anesthesia in infants and children with occult myopathies. Clin Pediatr (Phila) 1997;36:9-16
7. Robinson R, Carpenter D, Shaw MA, Halsall J, Hopkins P. Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mutat 2006;27:977-89
8. Larach MG. Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group. Anesth Analg 1989;69:511-5
9. Durham WJ, Aracena-Parks P, Long C, Rossi AE, Goonasekera SA, Boncompagni S, Galvan DL, Gilman CP, Baker MR, Shirokova N, Protasi F, Dirksen R, Hamilton SL. RyR1 S-nitrosylation underlies environmental heat stroke and sudden death in Y522S RyR1 knockin mice. Cell 2008;133:53-65
10. Chelu MG, Goonasekera SA, Durham WJ, Tang W, Lueck JD, Riehl J, Pessah IN, Zhang P, Bhattacharjee MB, Dirksen RT, Hamilton SL. Heat-and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse. FASEB J 2006;20:329-30
11. Fujii J, Otsu K, Zorzato F, de Leon S, Khanna VK, Weiler JE, O'Brien PJ, MacLennan DH. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science 1991;253:448-51
12. Ording H. Incidence of malignant hyperthermia in Denmark. Anesth Analg 1985;64:700-4
13. Monnier N, Krivosic-Horber R, Payen JF, Kozak-Ribbens G, Nivoche Y, Adnet P, Reyford H, Lunardi J. Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility. Anesthesiology 2002;97:1067-74
14. Ibarra M CA, Wu S, Murayama K, Minami N, Ichihara Y, Kikuchi H, Noguchi S, Hayashi YK, Ochiai R, Nishino I. Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing. Anesthesiology 2006;104:1146-54
15. Tammaro A, Di Martino A, Bracco A, Cozzolino S, Savoia G, Andria B, Cannavo A, Spagnuolo M, Piluso G, Aurino S, Nigro V. Novel missense mutations and unexpected multiple changes of RYR1 gene in 75 malignant hyperthermia families. Clin Genet 2011;79:438-47
16. Larach MG, Gronert GA, Allen GC, Brandom BW, Lehman EB. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006. Anesth Analg 2010;110:498-507